Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial.

Heudel PE, Van Praagh-Doreau I, Duvert B, Cauvin I, Hardy-Bessard AC, Jacquin JP, Stefani L, Vincent L, Dramais D, Guastalla JP, Blanc E, Belleville A, Lavergne E, Pérol D.

Support Care Cancer. 2019 May;27(5):1879-1889. doi: 10.1007/s00520-018-4449-x. Epub 2018 Sep 7.

PMID:
30194492
2.

Pleural lymphocyte-rich transudates in cats.

Probo M, Valenti V, Venco L, Paltrinieri S, Lavergne E, Trumel C, Bertazzolo W.

J Feline Med Surg. 2018 Aug;20(8):767-771. doi: 10.1177/1098612X17731045. Epub 2017 Sep 18.

PMID:
28920536
3.

Percutaneous guided biopsy for diagnosing suspected primary malignant bone tumors in pediatric patients: a safe, accurate, and cost-saving procedure.

Ceraulo A, Ouziel A, Lavergne E, Perrier L, Decouvelaere AV, Chotel F, Thiesse P, Marec-Berard P.

Pediatr Radiol. 2017 Feb;47(2):235-244. doi: 10.1007/s00247-016-3735-3. Epub 2016 Dec 10.

PMID:
27942776
4.

De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas.

Mebarki S, Désert R, Sulpice L, Sicard M, Desille M, Canal F, Dubois-Pot Schneider H, Bergeat D, Turlin B, Bellaud P, Lavergne E, Le Guével R, Corlu A, Perret C, Coulouarn C, Clément B, Musso O.

Oncotarget. 2016 Jun 28;7(26):39026-39043. doi: 10.18632/oncotarget.9346.

5.

"Fibrous nests" in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome.

Désert R, Mebarki S, Desille M, Sicard M, Lavergne E, Renaud S, Bergeat D, Sulpice L, Perret C, Turlin B, Clément B, Musso O.

Int J Biochem Cell Biol. 2016 Dec;81(Pt A):195-207. doi: 10.1016/j.biocel.2016.08.017. Epub 2016 Aug 18.

6.

Diversity and composition of estuarine and lagoonal fish assemblages of Socotra Island, Yemen.

Lavergne E, Zajonz U, Krupp F, Naseeb F, Aideed MS.

J Fish Biol. 2016 May;88(5):2004-26. doi: 10.1111/jfb.12964.

PMID:
27170111
7.

The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.

Foy JP, Tortereau A, Caulin C, Le Texier V, Lavergne E, Thomas E, Chabaud S, Perol D, Lachuer J, Lang W, Hong WK, Goudot P, Lippman SM, Bertolus C, Saintigny P.

Oncotarget. 2016 Jun 14;7(24):35932-35945. doi: 10.18632/oncotarget.8321.

8.

Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles.

Dufresne SS, Dumont NA, Boulanger-Piette A, Fajardo VA, Gamu D, Kake-Guena SA, David RO, Bouchard P, Lavergne É, Penninger JM, Pape PC, Tupling AR, Frenette J.

Am J Physiol Cell Physiol. 2016 Apr 15;310(8):C663-72. doi: 10.1152/ajpcell.00285.2015. Epub 2016 Jan 28.

9.

The coastal fishes and fisheries of the Socotra Archipelago, Yemen.

Zajonz U, Lavergne E, Klaus R, Krupp F, Aideed MS, Saeed FN.

Mar Pollut Bull. 2016 Apr 30;105(2):660-75. doi: 10.1016/j.marpolbul.2015.11.025. Epub 2016 Jan 19. Review.

PMID:
26795842
10.

Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.

Fayette J, Molin Y, Lavergne E, Montbarbon X, Racadot S, Poupart M, Ramade A, Zrounba P, Ceruse P, Pommier P.

Drug Des Devel Ther. 2015 Nov 26;9:6203-10. doi: 10.2147/DDDT.S81488. eCollection 2015.

11.

TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.

Kassem L, Deygas M, Fattet L, Lopez J, Goulvent T, Lavergne E, Chabaud S, Carrabin N, Chopin N, Bachelot T, Gillet G, Treilleux I, Rimokh R.

BMC Cancer. 2015 Jun 4;15:453. doi: 10.1186/s12885-015-1471-y.

12.

Role of JMJD6 in Breast Tumourigenesis.

Poulard C, Rambaud J, Lavergne E, Jacquemetton J, Renoir JM, Trédan O, Chabaud S, Treilleux I, Corbo L, Le Romancer M.

PLoS One. 2015 May 7;10(5):e0126181. doi: 10.1371/journal.pone.0126181. eCollection 2015.

13.

Osteoprotegerin protects against muscular dystrophy.

Dufresne SS, Dumont NA, Bouchard P, Lavergne É, Penninger JM, Frenette J.

Am J Pathol. 2015 Apr;185(4):920-6. doi: 10.1016/j.ajpath.2015.01.006. Epub 2015 Feb 21.

PMID:
25708645
14.

Does the chronic chemical contamination of a European flounder population decrease its thermal tolerance?

Lavergne E, Pedron N, Calves I, Claireaux G, Mazurais D, Zambonino-Infante J, Le Bayon N, Cahu C, Laroche J.

Mar Pollut Bull. 2015 Jun 30;95(2):658-64. doi: 10.1016/j.marpolbul.2015.01.006. Epub 2015 Jan 28.

PMID:
25636829
15.

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study.

Cassier PA, Kantor G, Bonvalot S, Lavergne E, Stoeckle E, Le Péchoux C, Meeus P, Sunyach MP, Vaz G, Coindre JM, Linassier C, Labib A, Delcambre C, Bay JO, Leyvraz S, Dubergé T, Lagrange JL, Duret A, Blay JY.

Ann Oncol. 2014 Sep;25(9):1854-60. doi: 10.1093/annonc/mdu202. Epub 2014 Jun 8.

PMID:
24914041
16.

Growth and survival of lung cancer cells: regulation by kallikrein-related peptidase 6 via activation of proteinase-activated receptor 2 and the epidermal growth factor receptor.

Michel N, Heuzé-Vourc'h N, Lavergne E, Parent C, Jourdan ML, Vallet A, Iochmann S, Musso O, Reverdiau P, Courty Y.

Biol Chem. 2014 Sep;395(9):1015-25. doi: 10.1515/hsz-2014-0124.

PMID:
24643912
17.

LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.

Bouchekioua-Bouzaghou K, Poulard C, Rambaud J, Lavergne E, Hussein N, Billaud M, Bachelot T, Chabaud S, Mader S, Dayan G, Treilleux I, Corbo L, Le Romancer M.

Int J Cancer. 2014 Sep 15;135(6):1307-18. doi: 10.1002/ijc.28781. Epub 2014 Mar 4.

18.

Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.

Lestrade L, De Bari B, Pommier P, Montbarbon X, Lavergne E, Ardiet JM, Carrie C.

Strahlenther Onkol. 2014 Jun;190(6):546-54. doi: 10.1007/s00066-014-0628-y. Epub 2014 Mar 11.

PMID:
24615188
19.

High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands.

Seigne C, Auret M, Treilleux I, Bonnavion R, Assade F, Carreira C, Goddard-Léon S, Lavergne E, Chabaud S, Garcia A, Mazoyer S, Lu J, Bachelot T, Frappart L, Zhang CX.

J Pathol. 2013 Mar;229(4):546-58. doi: 10.1002/path.4146.

PMID:
23180448
20.

Activation of rapid oestrogen signalling in aggressive human breast cancers.

Poulard C, Treilleux I, Lavergne E, Bouchekioua-Bouzaghou K, Goddard-Léon S, Chabaud S, Trédan O, Corbo L, Le Romancer M.

EMBO Mol Med. 2012 Nov;4(11):1200-13. doi: 10.1002/emmm.201201615. Epub 2012 Oct 15.

21.

ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.

Faget J, Bendriss-Vermare N, Gobert M, Durand I, Olive D, Biota C, Bachelot T, Treilleux I, Goddard-Leon S, Lavergne E, Chabaud S, Blay JY, Caux C, Ménétrier-Caux C.

Cancer Res. 2012 Dec 1;72(23):6130-41. doi: 10.1158/0008-5472.CAN-12-2409. Epub 2012 Oct 1.

22.

Paclitaxel and cetuximab combination efficiency after the failure of a platinum-based chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma.

Péron J, Ceruse P, Lavergne E, Buiret G, Pham BN, Chabaud S, Favier B, Girodet D, Zrounba P, Ramade A, Fayette J.

Anticancer Drugs. 2012 Oct;23(9):996-1001. doi: 10.1097/CAD.0b013e32835507e5.

PMID:
22643048
23.

Inhibition of Wnt/β-catenin signaling by a soluble collagen-derived frizzled domain interacting with Wnt3a and the receptors frizzled 1 and 8.

Hendaoui I, Lavergne E, Lee HS, Hong SH, Kim HZ, Parent C, Heuzé-Vourc'h N, Clément B, Musso O.

PLoS One. 2012;7(1):e30601. doi: 10.1371/journal.pone.0030601. Epub 2012 Jan 27. Erratum in: PLoS One. 2012;7(3). doi:10.1371/annotation/bd37b3ad-c242-4e77-9ef3-8e92d1f105f5.

24.

Permanent genetic resources added to Molecular Ecology Resources Database 1 October 2010-30 November 2010.

Molecular Ecology Resources Primer Development Consortium, Agostini C, Agudelo PA, Bâ K, Barber PA, Bisol PM, Brouat C, Burgess TI, Calves I, Carrillo Avila M, Chow S, Cordes L, Da Silva D, Dalecky A, De Meester L, Doadrio I, Dobigny G, Duplantier JM, Evison SE, Ford R, Fresneau D, Galetti PM Jr, Gauthier P, Geldof S, Granjon L, Guérin F, St J Hardy GE, Hernandez Escobar C, Hima K, Hu J, Huang L, Humeau L, Jansen B, Jaquemet S, Jiang ZQ, Jung SJ, Kim BS, Kim CH, Kim JO, Lai CH, Laroche J, Lavergne E, Lawton-Rauh A, Le Corre M, Leach MM, Lee J, Leo AE, Lichtenzveig J, Lin L, Linde CC, Liu SF, Marino IA, McKeown NJ, Nohara K, Oh MJ, Okamoto H, Oliver R, Olivera Angel M, Ornelas-García CP, Orsini L, Ostos Alfonso H, Othman AS, Papetti C, Patarnello T, Pedraza-Lara C, Piller KR, Poteaux C, Requier JB, Roziana MK, Semba Y, Sembene M, Shah RM, Shahril AR, Shao A, Shaw PW, Song L, Souza Ferreira R, Su YQ, Suzuki N, Tatard C, Taylor KM, Taylor PW, Thiam M, Valbuena R, Wang H, Yang BG, Yuan Q, Zajonz U, Zane L, Zhu L, Zhuang ZM, Zulaiha AR.

Mol Ecol Resour. 2011 Mar;11(2):418-21. doi: 10.1111/j.1755-0998.2010.02970.x. Epub 2011 Jan 21.

PMID:
21429157
25.

Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.

Lavergne E, Hendaoui I, Coulouarn C, Ribault C, Leseur J, Eliat PA, Mebarki S, Corlu A, Clément B, Musso O.

Oncogene. 2011 Jan 27;30(4):423-33. doi: 10.1038/onc.2010.432. Epub 2010 Sep 20.

26.

In vivo single cell detection of tumor-infiltrating lymphocytes with a clinical 1.5 Tesla MRI system.

Smirnov P, Poirier-Quinot M, Wilhelm C, Lavergne E, Ginefri JC, Combadière B, Clément O, Darrasse L, Gazeau F.

Magn Reson Med. 2008 Dec;60(6):1292-7. doi: 10.1002/mrm.21812.

27.

A cryptic frizzled module in cell surface collagen 18 inhibits Wnt/beta-catenin signaling.

Quélard D, Lavergne E, Hendaoui I, Elamaa H, Tiirola U, Heljasvaara R, Pihlajaniemi T, Clément B, Musso O.

PLoS One. 2008 Apr 2;3(4):e1878. doi: 10.1371/journal.pone.0001878.

28.

Androgen-regulated transcription factor AIbZIP in prostate cancer.

Labrie C, Lessard J, Ben Aicha S, Savard MP, Pelletier M, Fournier A, Lavergne E, Calvo E.

J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):237-44. Epub 2007 Sep 7. Review.

PMID:
17933519
29.

Characterization of the RSL1-dependent conditional expression system in LNCaP prostate cancer cells and development of a single vector format.

Lessard J, Aicha SB, Fournier A, Calvo E, Lavergne E, Pelletier M, Labrie C.

Prostate. 2007 Jun 1;67(8):808-19.

PMID:
17373718
30.

In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy.

Smirnov P, Lavergne E, Gazeau F, Lewin M, Boissonnas A, Doan BT, Gillet B, Combadière C, Combadière B, Clément O.

Magn Reson Med. 2006 Sep;56(3):498-508.

31.

Stage-specific expression of the Atce1/Tisp40alpha isoform of CREB3L4 in mouse spermatids.

El-Alfy M, Azzi L, Lessard J, Lavergne E, Pelletier M, Labrie C.

J Androl. 2006 Sep-Oct;27(5):686-94. Epub 2006 May 25.

32.

Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.

Nadif R, Mintz M, Rivas-Fuentes S, Jedlicka A, Lavergne E, Rodero M, Kauffmann F, Combadière C, Kleeberger SR.

Cytokine. 2006 Feb 7;33(3):171-8.

33.

Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease.

Lavergne E, Labreuche J, Daoudi M, Debré P, Cambien F, Deterre P, Amarenco P, Combadière C; GENIC Investigators.

Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):847-53. Epub 2005 Jan 27.

PMID:
15681302
34.

Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration.

Lavergne E, Combadière C, Iga M, Boissonnas A, Bonduelle O, Maho M, Debré P, Combadiere B.

J Immunol. 2004 Sep 15;173(6):3755-62.

35.

Antigen distribution drives programmed antitumor CD8 cell migration and determines its efficiency.

Boissonnas A, Combadiere C, Lavergne E, Maho M, Blanc C, Debré P, Combadiere B.

J Immunol. 2004 Jul 1;173(1):222-9.

36.

Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1.

Daoudi M, Lavergne E, Garin A, Tarantino N, Debré P, Pincet F, Combadière C, Deterre P.

J Biol Chem. 2004 May 7;279(19):19649-57. Epub 2004 Feb 27.

37.

Fractalkine mediates natural killer-dependent antitumor responses in vivo.

Lavergne E, Combadière B, Bonduelle O, Iga M, Gao JL, Maho M, Boissonnas A, Murphy PM, Debré P, Combadière C.

Cancer Res. 2003 Nov 1;63(21):7468-74.

38.

Nitric-oxide synthase is a mechanical signal transducer that modulates talin and vinculin expression.

Tidball JG, Spencer MJ, Wehling M, Lavergne E.

J Biol Chem. 1999 Nov 12;274(46):33155-60.

39.

Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle.

Tidball JG, Lavergne E, Lau KS, Spencer MJ, Stull JT, Wehling M.

Am J Physiol. 1998 Jul;275(1):C260-6. doi: 10.1152/ajpcell.1998.275.1.C260.

PMID:
9688857
41.

Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC-3 prostate cancer cells.

Reyes-Moreno C, Frenette G, Boulanger J, Lavergne E, Govindan MV, Koutsilieris M.

Prostate. 1995 May;26(5):260-9.

PMID:
7753711
42.

[Surface treatment of mineralized tissue: different approaches and prospects].

Goldberg M, Lys-Masanes I, De Lavergne E, Lacoudre N, Le Denmat D, Montluçon J.

Rev Orthop Dento Faciale. 1991;25(1):19-34. Review. French.

PMID:
1857904
43.

[Study of genetic markers of hepatitis B virus in 204 persons working in hospitals].

Catelle A, Christmann D, de Lavergne E.

Sem Hop. 1983 Sep 15;59(32):2225-7. French.

PMID:
6314506
44.

[Erythema multiforme. Isolation of Mycoplasma pneumoniae from skin lesions].

Canton P, Clozel M, Neiman L, Roche G, Dureux JB, Catelle A, de Lavergne E.

Nouv Presse Med. 1980 May 10;9(21):1516, 1518. French. No abstract available.

PMID:
6780976
45.

[Human infections by Mycoplasma pneumoniae (apropos of 30 cases)].

de Lavergne E, Catelle MA, Becker C.

Ann Med Interne (Paris). 1976 Feb;127(2):129-32. French. No abstract available.

PMID:
970798
46.

[Study of the incidence of complement-fixing antibodies against the cytomegalovirus in 339 subjects].

Georges JC, Rio Y, de Lavergne E.

Sem Hop. 1975 Apr 14;51(18):1213-8. French.

PMID:
175471
47.

[Simultaneous presence of Mycobacterium tuberculosis and Mycobacterium bovis in pathologic human fluids. Biological problems].

de Lavergne E, Georges JC, Gillot J, Catelle A, Janot C.

Sem Hop. 1973 Nov 26;49(48):3211-5. French. No abstract available.

PMID:
4364914
48.

[Lymphoblastic transformation test during syphilis].

Janot C, Grandidier M, Pupil P, Thomas JL, Beurey J, de Lavergne E.

Presse Med. 1971 Oct 16;79(43):1901-4. French. No abstract available.

PMID:
5128487
49.

[Humoral deficiencies during herpetic keratitis].

Cordier J, de Lavergne E, Georges JC, Raspiller A.

Presse Med. 1970 Nov 14;78(48):2134. French. No abstract available.

PMID:
4098251
50.

[Study of the immune reactions during recurrent herpetic infection in humans. New data on the importance of humoral deficiencies].

Georges JC, de Lavergne E, Foliguet JM, Bertrand F, Raspiller A.

Rev Immunol (Paris). 1970 Oct-Dec;34(6):309-18. French. No abstract available.

PMID:
4101845

Supplemental Content

Loading ...
Support Center